Evidence map›Paper›PMID 14665455›Full record

ArticleEukaryotic cell2003

The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling.

Cristina Reinoso-Martín, Christoph Schüller, Manuela Schuetzer-Muehlbauer, Karl Kuchler

Open access · diamondAbstract readComparative Study
In one paragraph

Article in Eukaryotic cell, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 194 citations in OpenAlex.

  1. Article
  2. Review
  3. Caspofungin paradoxical growth inFrontiers in cellular and infection microbiology · 2025
    Article
  4. Article
  5. Article
  6. Development of Echinocandin Resistance inJournal of fungi (Basel, Switzerland) · 2023
    Article
  7. Review
  8. Antifungal discovery.Current opinion in microbiology · 2022
    Review
  9. mSphere · 2022
    Article
  10. The role ofiScience · 2022
    Review
  11. Article
  12. Control of Gene Expression via the Yeast CWI Pathway.International journal of molecular sciences · 2022
    Review
  13. Review
  14. Frontiers in cellular and infection microbiology · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Cristina Reinoso-MartínDepartment of Medical Biochemistry, Division of Molecular Genetics, Max F. Perutz Laboratories, University and Biocenter of Vienna, A-1030 Vienna, Austria.
Christoph Schüller
Manuela Schuetzer-Muehlbauer
Karl Kuchler
Max Perutz Labs · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The echinocandin caspofungin is a new antifungal drug that blocks cell wall synthesis through inhibition of beta-(1-3)-glucan synthesis. Saccharomyces cerevisiae cells are able to tolerate rather high caspofungin concentrations, displaying high viability at low caspofungin doses. To identify yeast genes implicated in caspofungin tolerance, we performed a genome-wide microarray analysis. Strikingly, caspofungin treatment rapidly induces a set of genes from the protein kinase C (PKC) cell integrity signaling pathway, as well as those required for cell wall maintenance and architecture. The mitogen-activated protein kinase Slt2p is rapidly activated by phosphorylation, triggering signaling through the PKC pathway. Cells lacking genes such as SLT2, BCK1, and PKC1, as well as the caspofungin target gene, FKS1, display pronounced hypersensitivity, demonstrating that the PKC pathway is required for caspofungin tolerance. Notably, the cell surface integrity sensor Wsc1p, but not the sensors Wsc2-4p and Mid2p, is required for sensing caspofungin perturbations. The expression modulation of PKC target genes requires the transcription factor Rlm1p, which controls expression of several cell wall synthesis and maintenance genes. Thus, caspofungin-induced cell wall damage requires Wsc1p as a dedicated sensor to launch a protective response through the activated salvage pathway for de novo cell wall synthesis. Our results establish caspofungin as a specific activator of Slt2p stress signaling in baker's yeast.

Indexed as

Peptides, CyclicAntifungal AgentsCaspofunginCell ExtractsCells, CulturedCell SurvivalDNA-Binding ProteinsDown-RegulationDrug ToleranceEchinocandinsEnzyme ActivationFungal ProteinsGene ExpressionGenes, FungalKineticsLipopeptidesAntifungal AgentsCaspofunginCell ExtractsDNA-Binding ProteinsEchinocandinsFungal ProteinsLipopeptidesMitogen-Activated Protein KinasesPeptidesPeptides, CyclicProtein Kinase CRepressor ProteinsRIM101 protein, S cerevisiaeRNA, MessengerSaccharomyces cerevisiae ProteinsSLT2 protein, S cerevisiae

Identifiers

PMID14665455
PMCPMC326656
OpenAlexW2106031809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.